MedTrace Logo

Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy

NCT02452060 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2020-03-16

Study results available
· View outcomes & findings →

Summary

This is a randomized, double-blind, placebo-controlled, two-arm parallel, single-center study. One hundred subjects (50 in each arm) will be enrolled. Subjects, between the ages 18 and 65, undergoing laparoscopic gastric bypass or sleeve gastrectomy will be recruited and consented during the preadmission visit prior to surgery.

Conditions

  • Pain
  • Postoperative Depression

Interventions

DRUG

Ketamine

0.4mg/kg infusion

OTHER

Placebo Comparator

0.4mg/kg infusion

Sponsors & Collaborators

Principal Investigators

  • Jing Wang, MD, PHD · NYU School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2017-04-13
Completion
2017-04-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02452060 on ClinicalTrials.gov